Your browser doesn't support javascript.
loading
Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study.
Wang, Bruce; Ventura, Paolo; Takase, Kei-Ichiro; Thapar, Manish; Cassiman, David; Kubisch, Ilja; Liu, Shangbin; Sweetser, Marianne T; Balwani, Manisha.
Affiliation
  • Wang B; Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, CA, 94143, USA. Bruce.Wang@ucsf.edu.
  • Ventura P; University of Modena and Reggio Emilia, Modena, Italy.
  • Takase KI; Iizuka Hospital, Iizuka, Japan.
  • Thapar M; Thomas Jefferson University, Philadelphia, PA, USA.
  • Cassiman D; University Hospital Leuven, Leuven, Belgium.
  • Kubisch I; Klinikum Chemnitz, Chemnitz, Germany.
  • Liu S; Alnylam Pharmaceuticals, Cambridge, MA, USA.
  • Sweetser MT; Alnylam Pharmaceuticals, Cambridge, MA, USA.
  • Balwani M; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Orphanet J Rare Dis ; 17(1): 327, 2022 08 26.
Article in En | MEDLINE | ID: mdl-36028858
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Porphyrias, Hepatic / Porphyria, Acute Intermittent Type of study: Clinical_trials Limits: Humans Language: En Journal: Orphanet J Rare Dis Journal subject: MEDICINA Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Porphyrias, Hepatic / Porphyria, Acute Intermittent Type of study: Clinical_trials Limits: Humans Language: En Journal: Orphanet J Rare Dis Journal subject: MEDICINA Year: 2022 Type: Article Affiliation country: United States